Annual Financials for Apellis Pharmaceuticals Inc.
Assets
Fiscal year is January-December. All values USD millions. |
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Cash & Short Term Investments |
175.64M | 176.27M | 351.99M | 878.91M | 702.11M | |
Cash Only |
175.64M | 176.27M | 351.99M | 567.05M | 641.76M | |
Short-Term Investments |
- | - | - | 311.87M | 60.36M | |
Cash & Short Term Investments Growth |
- | 0.36% | 99.69% | 149.70% | -20.12% | |
Cash & ST Investments / Total Assets |
96.44% | 86.60% | 90.43% | 91.50% | 79.63% | |
Total Accounts Receivable |
- | - | - | - | 10.1M | |
Accounts Receivables, Net |
- | - | - | - | 10.1M | |
Accounts Receivables, Gross |
- | - | - | - | 10.1M | |
Bad Debt/Doubtful Accounts |
- | - | - | - | - | |
Other Receivables |
- | - | - | - | - | |
Accounts Receivable Growth |
- | - | - | - | - | |
Accounts Receivable Turnover |
- | - | - | - | 6.59 | |
Inventories |
- | - | - | - | 16.29M | |
Finished Goods |
- | - | - | - | 10.6M | |
Work in Progress |
- | - | - | - | - | |
Raw Materials |
- | - | - | - | 5.7M | |
Progress Payments & Other |
- | - | - | - | - | |
Other Current Assets |
6.37M | 26.17M | 21.11M | 38.28M | 95.55M | |
Miscellaneous Current Assets |
1.31M | 1.84M | 1.31M | 26.88M | 70.68M | |
Total Current Assets |
182.02M | 202.44M | 373.09M | 917.19M | 824.05M | |
|
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Net Property, Plant & Equipment |
- | - | 15.77M | 24.52M | 26.08M | |
Property, Plant & Equipment - Gross |
- | - | - | - | - | |
Buildings |
- | - | - | - | - | |
Land & Improvements |
- | - | - | - | - | |
Computer Software and Equipment |
- | - | - | - | - | |
Other Property, Plant & Equipment |
- | - | - | - | - | |
Accumulated Depreciation |
- | - | - | - | - | |
Total Investments and Advances |
- | - | - | - | - | |
Other Long-Term Investments |
- | - | - | - | - | |
Long-Term Note Receivable |
- | - | - | - | - | |
Intangible Assets |
- | - | - | - | - | |
Net Goodwill |
- | - | - | - | - | |
Net Other Intangibles |
- | - | - | - | - | |
Other Assets |
116,150 | 1.09M | 385,090 | 18.86M | 31.64M | |
Tangible Other Assets |
116,150 | 1.09M | 385,088 | 18.86M | 31.64M | |
Total Assets |
182.13M | 203.53M | 389.24M | 960.57M | 881.77M | |
Assets - Total - Growth |
- | 11.75% | 91.24% | 146.78% | -8.20% | |
Liabilities & Shareholders' Equity
|
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
ST Debt & Current Portion LT Debt |
- | 1.67M | 2.61M | 3.69M | 4.12M | |
Short Term Debt |
- | - | 2.61M | 3.69M | - | |
Current Portion of Long Term Debt |
- | 1.67M | - | - | - | |
Accounts Payable |
- | - | 8.36M | 8.48M | 16.91M | |
Accounts Payable Growth |
- | - | - | 1.39% | 99.47% | |
Income Tax Payable |
- | - | - | - | - | |
Other Current Liabilities |
6.55M | 15.36M | 54.78M | 116.17M | 110.82M | |
Dividends Payable |
- | - | - | - | - | |
Accrued Payroll |
251,491 | 269,046 | 11.44M | 22.9M | 25.21M | |
Miscellaneous Current Liabilities |
6.3M | 15.09M | 43.34M | 93.27M | 85.61M | |
Total Current Liabilities |
6.55M | 17.02M | 65.75M | 128.33M | 131.85M | |
Long-Term Debt |
26.39M | 25.38M | 154.42M | 374.05M | 206.11M | |
Long-Term Debt excl. Capitalized Leases |
26.39M | 25.38M | 142.57M | 358.83M | 189.02M | |
Non-Convertible Debt |
26.39M | 25.38M | 142.57M | 358.83M | 189.02M | |
Convertible Debt |
- | - | - | - | - | |
Capitalized Lease Obligations |
- | - | - | - | - | |
Provision for Risks & Charges |
- | - | - | - | - | |
Deferred Taxes |
- | - | - | - | - | |
Deferred Taxes - Credit |
- | - | - | - | - | |
Deferred Taxes - Debit |
- | - | - | - | - | |
Other Liabilities |
244,290 | 158,780 | 134.84M | 253.64M | 345.15M | |
Other Liabilities (excl. Deferred Income) |
244,292 | 158,783 | 134.84M | 253.64M | 345.15M | |
Deferred Income |
- | - | - | - | - | |
Total Liabilities |
33.19M | 42.56M | 355.02M | 756.01M | 683.1M | |
Non-Equity Reserves |
- | - | - | - | - | |
Total Liabilities / Total Assets |
18.22% | 20.91% | 91.21% | 78.70% | 77.47% | |
Preferred Stock (Carrying Value) |
- | - | - | - | - | |
Redeemable Preferred Stock |
- | - | - | - | - | |
Non-Redeemable Preferred Stock |
- | - | - | - | - | |
Common Equity (Total) |
148.94M | 160.97M | 34.23M | 204.56M | 198.66M | |
Common Stock Par/Carry Value |
5,033 | 5,628 | 6,393 | 8,000 | 10,000 | |
Retained Earnings |
(149.26M) | (276.77M) | (581.47M) | (926.35M) | (1.66B) | |
ESOP Debt Guarantee |
- | - | - | - | - | |
Cumulative Translation Adjustment/Unrealized For. Exch. Gain |
- | (122,807) | (153,775) | (109,000) | (2.09M) | |
Unrealized Gain/Loss Marketable Securities |
- | - | - | (8,000) | 1,000 | |
Revaluation Reserves |
- | - | - | - | - | |
Treasury Stock |
- | - | - | - | - | |
Common Equity / Total Assets |
81.78% | 79.09% | 8.79% | 21.30% | 22.53% | |
Total Shareholders' Equity |
148.94M | 160.97M | 34.23M | 204.56M | 198.66M | |
Total Shareholders' Equity / Total Assets |
81.78% | 79.09% | 8.79% | 21.30% | 22.53% | |
Accumulated Minority Interest |
- | - | - | - | - | |
Total Equity |
148.94M | 160.97M | 34.23M | 204.56M | 198.66M | |
Liabilities & Shareholders' Equity |
182.13M | 203.53M | 389.24M | 960.57M | 881.77M | |